1. Home
  2. ZVRA vs BXC Comparison

ZVRA vs BXC Comparison

Compare ZVRA & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • BXC
  • Stock Information
  • Founded
  • ZVRA 2006
  • BXC 2004
  • Country
  • ZVRA United States
  • BXC United States
  • Employees
  • ZVRA N/A
  • BXC N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • BXC Wholesale Distributors
  • Sector
  • ZVRA Health Care
  • BXC Consumer Discretionary
  • Exchange
  • ZVRA Nasdaq
  • BXC Nasdaq
  • Market Cap
  • ZVRA 481.7M
  • BXC 551.4M
  • IPO Year
  • ZVRA 2015
  • BXC 2004
  • Fundamental
  • Price
  • ZVRA $11.05
  • BXC $71.31
  • Analyst Decision
  • ZVRA Strong Buy
  • BXC Strong Buy
  • Analyst Count
  • ZVRA 9
  • BXC 3
  • Target Price
  • ZVRA $23.25
  • BXC $91.00
  • AVG Volume (30 Days)
  • ZVRA 1.2M
  • BXC 136.4K
  • Earning Date
  • ZVRA 08-12-2025
  • BXC 07-29-2025
  • Dividend Yield
  • ZVRA N/A
  • BXC N/A
  • EPS Growth
  • ZVRA N/A
  • BXC N/A
  • EPS
  • ZVRA N/A
  • BXC 3.42
  • Revenue
  • ZVRA $40,588,000.00
  • BXC $2,947,258,000.00
  • Revenue This Year
  • ZVRA $303.00
  • BXC $2.76
  • Revenue Next Year
  • ZVRA $77.66
  • BXC $4.81
  • P/E Ratio
  • ZVRA N/A
  • BXC $21.10
  • Revenue Growth
  • ZVRA 46.47
  • BXC N/A
  • 52 Week Low
  • ZVRA $6.19
  • BXC $63.14
  • 52 Week High
  • ZVRA $13.16
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 50.02
  • BXC 40.67
  • Support Level
  • ZVRA $10.69
  • BXC $77.93
  • Resistance Level
  • ZVRA $11.37
  • BXC $80.31
  • Average True Range (ATR)
  • ZVRA 0.49
  • BXC 3.52
  • MACD
  • ZVRA -0.21
  • BXC -1.26
  • Stochastic Oscillator
  • ZVRA 12.50
  • BXC 18.39

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: